Substituted melanocortin receptor-specific piperazine compounds
    21.
    发明授权
    Substituted melanocortin receptor-specific piperazine compounds 有权
    取代的黑皮质素受体特异性哌嗪化合物

    公开(公告)号:US07718802B2

    公开(公告)日:2010-05-18

    申请号:US11099814

    申请日:2005-04-05

    CPC分类号: C07D241/04 C07D403/06

    摘要: Melanocortin receptor-specific compounds of the general formulas and pharmaceutically acceptable salts thereof, where J is a substituted or unsubstituted monocyclic or bicyclic ring structure, L is a linker, W is a heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor, Q includes a substituted or unsubstituted aromatic carbocyclic ring, R6, R7, y and z are as defined in the specification, and the carbon atom marked with an asterisk can have any stereochemical configuration, and optionally with one or two additional ring substituents as defined, which compounds bind to one or more melanocortin receptors and are optionally an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, and methods for the use of the compounds of the invention.

    摘要翻译: 其中J为取代或未取代的单环或双环结构的黑皮质素受体特异性化合物及其药学上可接受的盐,L为连接基,W为至少一个阳离子中心,氢键供体或氢的杂原子单元 键接受体,Q包括取代或未取代的芳族碳环,R6,R7,y和z如说明书中所定义,并且具有星号的碳原子可以具有任何立体化学构型,并且任选具有一个或两个另外的环取代基 定义为哪些化合物结合一种或多种黑皮质素受体,并且任选地是激动剂,部分激动剂,拮抗剂,反向激动剂的反向激动剂或拮抗剂,并且可用于治疗一种或多种黑皮质素受体相关 条件或障碍,以及使用本发明化合物的方法。

    Pyrrolidine melanocortin-specific compounds
    22.
    发明授权
    Pyrrolidine melanocortin-specific compounds 有权
    吡咯烷黑皮质素特异性化合物

    公开(公告)号:US07601753B2

    公开(公告)日:2009-10-13

    申请号:US11680932

    申请日:2007-03-01

    IPC分类号: A61K31/40 C07D207/04

    摘要: Melanocortin receptor-specific pyrrolidine compounds having the structure: and stereoisomer and pharmaceutically acceptable salts thereof, where R1, R2, and R3 are as described in the specification, preferably where R3 is a D-amino acid with at least one substituted or unsubstituted phenyl or naphthyl aromatic ring, and where R3 optionally further includes an amine capping group or from one to three additional amino acid residues, optionally with an amine capping group, which compounds are agonists, antagonists or mixed agonists and antagonists at one or more melanocortin receptors, and having utility in the treatment of melanocortin receptor-related disorders and conditions. Methods of synthesis of compounds of structure (I), pharmaceutical compositions containing a compound of structure (I) and methods relating to the use thereof are also disclosed.

    摘要翻译: 具有以下结构的黑皮质素受体特异性吡咯烷化合物及其立体异构体和药学上可接受的盐,其中R 1,R 2和R 3如说明书中所述,优选其中R 3是具有至少一个取代或未取代的苯基的D-氨基酸或 并且其中R 3任选地进一步包括胺封端基团或一至三个另外的氨基酸残基,任选地具有胺封端基团,所述化合物是一种或多种黑皮质素受体的激动剂,拮抗剂或混合激动剂和拮抗剂,以及 可用于治疗黑皮质素受体相关疾病和病症。 还公开了结构(I)化合物的合成方法,含有结构(I)化合物的药物组合物及其使用方法。

    Melanocortin receptor-specific piperazine compounds with diamine groups
    24.
    发明授权
    Melanocortin receptor-specific piperazine compounds with diamine groups 有权
    具有二胺基团的黑皮质素受体特异性哌嗪化合物

    公开(公告)号:US07968548B2

    公开(公告)日:2011-06-28

    申请号:US11464053

    申请日:2006-08-11

    IPC分类号: A61K31/495 C07D241/04

    摘要: Melanocortin receptor-specific compounds with diamine groups of the general formula and pharmaceutically acceptable salts thereof, where W is a diamine heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor, J, Q, L1, L2, L3, R1a, R1b, R2a, R2b and X are as defined in the specification, and the carbon atom marked with an asterisk can have any stereochemical configuration. Compounds disclosed herein bind to one or more melanocortin receptors and may be an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist as to one or more melanocortin receptors, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, including specifically treatment of obesity and related conditions.

    摘要翻译: 具有通式的二胺基的黑皮质素受体特异性化合物及其药学上可接受的盐,其中W是具有至少一个阳离子中心,氢键供体或氢键受体的二胺杂原子单元,J,Q,L1,L2,L3, R1a,R1b,R2a,R2b和X如本说明书中所定义,并且带有星号的碳原子可具有任何立体化学构型。 本文公开的化合物结合一种或多种黑皮质素受体,并且可以是关于一种或多种黑皮质素受体的反向激动剂的激动剂,部分激动剂,拮抗剂,反向激动剂或拮抗剂,并且可以用于治疗一种或多种黑皮质素受体 更多的黑皮质素受体相关病症或障碍,包括特别治疗肥胖症和相关病症。

    Opioid metallopeptide compositions and methods
    25.
    发明授权
    Opioid metallopeptide compositions and methods 失效
    阿片类金属肽组合物和方法

    公开(公告)号:US06979436B2

    公开(公告)日:2005-12-27

    申请号:US10150979

    申请日:2002-05-17

    摘要: Metallopeptides and metallopeptide combinatorial libraries specific for opioids receptors are provided, for use in biological, pharmaceutical and related applications. The metallopeptides and combinatorial libraries are made of peptides, peptidomimetics and peptide-like constructs, in which the peptide, peptidomimetic or construct is conformationally fixed in a biologically active configuration specific for one or more opioid receptors on complexation of a metal ion-binding portion thereof with a metal ion.

    摘要翻译: 提供了对阿片类受体特异性的金属肽和金属肽组合文库,用于生物,药物和相关应用。 金属肽和组合文库由肽,肽模拟物和肽样构建体制成,其中肽,拟肽或构建体在一种或多种阿片受体特异性的生物活性构型中被构象地固定在金属离子结合部分的络合物上 与金属离子。

    Linear and cyclic melanocortin receptor-specific peptidomimetics
    26.
    发明授权
    Linear and cyclic melanocortin receptor-specific peptidomimetics 有权
    线性和环状黑皮质素受体特异性肽模拟物

    公开(公告)号:US08114844B2

    公开(公告)日:2012-02-14

    申请号:US12244880

    申请日:2008-10-03

    摘要: Linear and cyclic peptidomimetics which bind to one or more melanocortin receptors are provided, which peptidomimetics include at least one ring-constrained amino acid surrogate of formula I: where R1, R2, R3, R4, R5, R6, R7, R8, and y are as defined in the specification, together with methods for synthesizing ring-constrained amino acid surrogates of formula I and peptidomimetics incorporating the same, and methods of use of peptidomimetics in the treatment of various diseases, syndromes and conditions.

    摘要翻译: 提供了结合一种或多种黑皮质素受体的线性和环肽模拟物,其中肽模拟物包括至少一个式I的环受限氨基酸替代物:其中R1,R2,R3,R4,R5,R6,R7,R8和y 以及用于合成式I的环受限制的氨基酸替代物的方法和包含其的肽模拟物的方法,以及使用肽模拟物治疗各种疾病,综合征和病症的方法。

    Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction
    28.
    发明申请
    Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction 有权
    用于治疗性功能障碍的黑皮质素受体特异性肽

    公开(公告)号:US20110065652A1

    公开(公告)日:2011-03-17

    申请号:US12952238

    申请日:2010-11-23

    IPC分类号: A61K38/12 C07K7/00 A61P15/00

    摘要: A melanocortin receptor agonist cyclic peptide of the formula where R, x and y are as defined in the specification, compositions and formulations including the peptide of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including sexual dysfunction such as male erectile dysfunction and female sexual dysfunction.

    摘要翻译: 下式的黑皮质素受体激动剂环肽其中R,x和y如说明书中所定义,包括上述式的肽的组合物和制剂,以及预防,改善或治疗黑皮质素受体介导的疾病,适应症,条件 和综合征,包括性功能障碍如男性勃起功能障碍和女性性功能障碍。

    Substituted melanocortin receptor-specific single acyl piperazine compounds
    29.
    发明授权
    Substituted melanocortin receptor-specific single acyl piperazine compounds 有权
    取代的黑皮质素受体特异性单酰哌嗪化合物

    公开(公告)号:US07727991B2

    公开(公告)日:2010-06-01

    申请号:US11464051

    申请日:2006-08-11

    IPC分类号: A61K31/495 C07D295/10

    CPC分类号: C07D241/04 C07D403/12

    摘要: Melanocortin receptor-specific compounds of the general formula and pharmaceutically acceptable salts thereof, where J is a substituted or unsubstituted monocyclic or bicyclic ring structure, W is a heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor, Q is a substituted or unsubstituted aromatic carbocyclic ring group, L, R2a, R2b, R3a, R3b, r, x and y are as defined in the specification, and the carbon atoms marked with an asterisk can have any stereochemical configuration. Compounds disclosed herein bind to one or more melanocortin receptors and may be an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist as to one or more melanocortin receptors, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, including specifically treatment of obesity and related conditions.

    摘要翻译: 其中J是取代或未取代的单环或双环结构,W是具有至少一个阳离子中心,氢键给体或氢键受体的杂原子单元,Q是通式的黑皮质素受体特异性化合物及其药学上可接受的盐 取代或未取代的芳族碳环基,L,R2a,R2b,R3a,R3b,r,x和y如说明书中所定义,并且带有星号的碳原子可以具有任何立体化学构型。 本文公开的化合物结合一种或多种黑皮质素受体,并且可以是关于一种或多种黑皮质素受体的反向激动剂的激动剂,部分激动剂,拮抗剂,反向激动剂或拮抗剂,并且可以用于治疗一种或多种黑皮质素受体 更多的黑皮质素受体相关病症或障碍,包括特别治疗肥胖症和相关病症。

    Melanocortin receptor-specific piperazine and keto-piperazine compounds
    30.
    发明授权
    Melanocortin receptor-specific piperazine and keto-piperazine compounds 有权
    黑皮质素受体特异性哌嗪和酮 - 哌嗪化合物

    公开(公告)号:US07727990B2

    公开(公告)日:2010-06-01

    申请号:US11464069

    申请日:2006-08-11

    IPC分类号: A61K31/497 C07D295/067

    摘要: Melanocortin receptor-specific compounds of the general formula and pharmaceutically acceptable salts thereof, where X, W, J, Q, L1, L2, L3, R1a, R1b, R2a, and R2b are as defined in the specification, and the carbon atom marked with an asterisk can have any stereochemical configuration. Compounds disclosed herein bind to one or more melanocortin receptors and may be an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist as to one or more melanocortin receptors, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, including specifically treatment of obesity and related conditions.

    摘要翻译: 通式的黑皮质素受体特异性化合物及其药学上可接受的盐,其中X,W,J,Q,L1,L2,L3,R1a,R1b,R2a和R2b如本说明书中所定义, 星号可以具有任何立体化学构型。 本文公开的化合物结合一种或多种黑皮质素受体,并且可以是关于一种或多种黑皮质素受体的反向激动剂的激动剂,部分激动剂,拮抗剂,反向激动剂或拮抗剂,并且可以用于治疗一种或多种黑皮质素受体 更多的黑皮质素受体相关病症或障碍,包括特别治疗肥胖症和相关病症。